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Two populations of Nkx2-1+ progenitors in the
developing foregut endoderm give rise to the entire
postnatal lung and thyroid epithelium, but little is
known about these cells because they are difficult
to isolate in a pure form. We demonstrate here the
purification and directed differentiation of primordial
lung and thyroid progenitors derived from mouse
embryonic stem cells (ESCs). Inhibition of TGFb
and BMP signaling, followed by combinatorial
stimulation of BMP and FGF signaling, can specify
these cells efficiently from definitive endodermal pre-
cursors. When derived using Nkx2-1GFP knockin
reporter ESCs, these progenitors can be purified for
expansion in culture and have a transcriptome that
overlaps with developing lung epithelium. Upon
induction, they can express a broad repertoire of
markers indicative of lung and thyroid lineages and
can recellularize a 3D lung tissue scaffold. Thus, we
have derived a pure population of progenitors able
to recapitulate the developmental milestones of
lung/thyroid development.
INTRODUCTION
Early in embryonic development definitive endoderm progenitor
cells of the developing foregut are specified into organ domains,
such as the primordial thyroid, lung, liver, and pancreas fields
(Cardoso and Kotton, 2008; Serls et al., 2005). These primordial
progenitors then give rise to all the differentiated epithelial
progeny of each endodermally derived tissue. Hence, those398 Cell Stem Cell 10, 398–411, April 6, 2012 ª2012 Elsevier Inc.interested in purifying thyroid, lung, liver, or pancreatic stem or
progenitor cells for disease therapies are increasingly focused
on using the developing embryo as a roadmap to derive
these progenitors in vitro through the directed differentiation of
pluripotent embryonic stem cells (ESCs) whose phenotype
resembles the early embryo (Gadue et al., 2005). Based on this
developmental approach, definitive endoderm progenitors
have been efficiently derived from mouse and human ESCs
using Activin A (hereafter Activin) to induce embryonic Nodal/Ac-
tivin signaling (D’Amour et al., 2005; Gouon-Evans et al., 2006;
Kubo et al., 2004). The definitive endoderm cells derived in this
manner have been presumed to be broadly multipotent;
however, the most anterior foregut endodermal lineages, such
as thymus, thyroid, and lung epithelia, have been difficult to
derive from these progenitors (Green et al., 2011), in contrast
to more posterior foregut or hindgut endodermal tissues, such
as hepatic and intestinal lineages (Gouon-Evans et al., 2006;
Spence et al., 2011).
Although specific markers or ‘‘knockin reporter cell lines’’
(such as Pdx1GFP mouse ESCs) have been employed to facilitate
isolation of inefficiently specified foregut progenitors, such as
those of pancreatic lineage (Micallef et al., 2005), no tools have
been engineered that can allow the isolation of the most primor-
dial murine lung and thyroid progenitors. Consequently, lung and
thyroid epithelia remain among the least studied lineages
derived from ESCs in vitro to date. In heterogeneous cultures
of differentiating ESCs, induction of late markers of developing
lung (Ali et al., 2002; Ameri et al., 2010; Coraux et al., 2005;
Qin et al., 2005; Rippon et al., 2004, 2006; Roszell et al., 2009;
Samadikuchaksaraei et al., 2006; Van Vranken et al., 2005;
Wang et al., 2007; Winkler et al., 2008) and thyroid (Arufe et al.,
2006, 2009; Jiang et al., 2010;Ma et al., 2009), such as surfactant
protein C (SPC) and thyroglobulin, respectively, have been re-
ported, but their expression appears to be stochastic, and the
cells expressing these markers have been difficult to expand
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tion, all lung or thyroid epithelia must first progress through
a primordial progenitor stage defined by the onset of expression
of the homeodomain-containing transcription factor, Nkx2-1
(also known as thyroid transcription factor-1; Ttf1 or Titf1).
However, lack of specificity of this marker has made it difficult
to utilize for ESC differentiation studies, a hurdle common to
many ESC-based model systems where differentiated lineages
of diverse germ layers must first proceed through a progenitor
state expressing a transcription factor that lacks complete
specificity for that lineage.
Despite its lack of specificity, Nkx2-1 is known to be a key
transcriptional regulator of lung, thyroid, and forebrain develop-
ment, as evidenced by Nkx2-1 knockout mice, which display
abnormalities in forebrain development and lung/thyroid agen-
esis (Kimura et al., 1996; Minoo et al., 1999). In addition, humans
born with Nkx2-1 gene mutations develop pediatric lung
disease, hypothyroidism, and neurological impairment (Krude
et al., 2002). Inability to access the presumed very rare, multipo-
tent primordial lung and thyroid progenitors at their moment of
specification within endoderm has resulted in a lack of informa-
tion about their phenotype, genetic programs, or epigenetic
mechanisms that control their differentiation. In turn this has
limited any rational approach to try to developmentally derive
their equivalents from ESCs in culture.
Here we present an Nkx2-1 knockin ESC line and reporter
mouse that has allowed us to develop serum-free culture proto-
cols for the step-wise derivation of pure populations of Nkx2-1
progenitors that exhibit the differentiation repertoire of Nkx2-1+
lung/thyroid endodermal and neuroectodermal primordia known
to be present in the developing embryo. We find that definitive
endoderm derived from ESCs with Activin alone resists lung or
thyroid lineage specification, andwe propose that stage-specific
inhibition of BMP and TGFb signaling renders these endodermal
progenitors competent to specify efficiently into Nkx2-1+ endo-
dermal lung or thyroid progenitors with little if any contamination
of Nkx2-1+ neuroectoderm. Following BMP/TGFb inhibition,
subsequent combinatorial induction of BMP and FGF signaling
promotes initial lineage specification of endodermal Nkx2-1+
lung and thyroid progenitors. These primordial progenitors can
be sorted to purity and thereafter expanded and differentiated
in culture. In contrast, prolonged exposure to BMP/TGFb inhib-
itors results in highly efficient derivation in culture of Nkx2-1+
neuroectodermal progeny that do not express any endodermal,
lung, or thyroid markers, revealing precise control in culture over
the germ layer lineage specification of cells expressing an other-
wise nonspecific transcriptional regulator.
RESULTS
Inhibition of TGFb and BMP Signaling Renders
ESC-Derived Endoderm Competent to Specify
into Nkx2-1+ Progenitors
In order to optimize culture conditions for the derivation of Nkx2-
1-expressing candidate lung/thyroid progenitors, we generated
an Nkx2-1 reporter ESC line (hereafter Nkx2-1GFP) by targeting
a GFP reporter gene to the Nkx2-1 locus using homologous
recombination (Figures S1A and S1B). In Nkx2-1GFP mice gener-
ated from this cell line, the GFP reporter was expressed in thedeveloping forebrain, lung, and thyroid in the expected distribu-
tion of endogenous Nkx2-1 mRNA and protein (Figure 1 and
Figure S1 available online).
To test faithfulness and specificity of the Nkx2-1GFP ESC
reporter line in vitro, we first derived embryoid bodies (EBs) using
published serum-free culture conditions supplemented with
Activin (Christodoulou et al., 2011; Gouon-Evans et al., 2006;
Kubo et al., 2004), resulting in >80% efficient definitive endo-
derm induction in 5 days but no detectable Nkx2-1 expression
(Figure S2). To induce Nkx2-1 expression, we then exposed
day 5 ESC-endoderm cells to either hepatic inducing conditions,
which include low levels of FGF2 (Gouon-Evans et al., 2006), or
high levels of FGF2 alone, based on previous reports suggesting
that FGF2 secreted by adjacent mesoderm specifies lung
epithelium from endoderm (Serls et al., 2005). In either condition,
we observed inefficient induction of the GFP reporter in rare cells
by day 12 (0.1% and 1% of cells, respectively; Figure S1G).
Flow-cytometry-based cell sorting of GFP+ cells distinguished
the entirety of Nkx2-1 mRNA-expressing cells, analyzed by
RT-PCR (Figure S1G). These results confirmed that the expres-
sion of GFP faithfully and specifically reports induction of the
endogenous Nkx2-1 locus in this cell line; however, Nkx2-1
induction in Activin-exposed ESCs was inefficient. Moreover,
this rare GFP+ population was heterogeneous, expressing
markers of neuroectoderm (Pax6 and Tuj1), very low levels of
the endodermal marker Foxa2 and the early thyroid marker
Pax8, and expressing little to no differentiated thyroid (thyroglob-
ulin) or differentiated lung (SPC or CC10) markers. (Figure S3).
FGF1 or Wnt3a, alternative factors previously reported to induce
lung lineage within developing endoderm (Goss et al., 2009;
Harris-Johnson et al., 2009; Serls et al., 2005), similarly failed
to efficiently induce endodermal Nkx2-1+ lineages from ESC-
derived endodermal progenitors (Figure S3).
Given the capacity of ESC-derived endoderm to form hepatic
lineages, but its apparently limited capacity to form Nkx2-1+
endodermal lineages, we considered the possibility that day 5
ESC-endoderm cells might display significant anterior-posterior
(AP) patterning toward endodermal domains other than lung or
thyroid. Indeed, interrogation of our microarray database detail-
ing the transcriptome of day 5 ESC-endoderm (Christodoulou
et al., 2011) suggested upregulation of Hex and Foxa3 (Fig-
ure S4), markers that indicate AP patterning in the endodermal
gut tube of embryos (Martinez Barbera et al., 2000; Monaghan
et al., 1993). To explore this possibility further, we employed
an ESC reporter line (Figures 1A and 1B) containing Foxa2-
hCD4 and Foxa3-hCD25 knockin reporters (Gadue et al.,
2009). ESC-derived endoderm coexpressed Foxa3 in approxi-
mately 40% of Foxa2+ cells, indicating significant AP patterning
of the cells in response to Activin (Figure 1B). By FACS analysis,
these double positive cells appeared to arise within the Foxa2+
population between days 4 and 5 of differentiation. This
Foxa2+/Foxa3+ population has previously been demonstrated
to rapidly specify into hepatic lineages in the presence of
BMP4 (Gadue et al., 2009).
Given the role of Activin and BMP4 in the patterning and
specification of endodermal Foxa2+/Foxa3+ cells (Gadue et al.,
2009; Gouon-Evans et al., 2006), and based on reports that
precise modulation of TGFb and BMP signaling can optimize
early germ layer patterning in vivo (Tiso et al., 2002) as well asCell Stem Cell 10, 398–411, April 6, 2012 ª2012 Elsevier Inc. 399
Figure 1. Inhibition of BMPand TGFbSignaling Alters Endodermal Patterning andModulates Competence of ESCs toDifferentiate into either
Endodermal Nkx2-1+ or Neuronal Nkx2-1+ Cells
(A) Schematic of AP patterning of the endodermal gut tube in the developing embryo (E8.5–E9). Domains of expression of genes that demarcate prospective
organ fields are shown.
(B) Kinetics of expression of knockin reporters, Foxa2-hCD4 and Foxa3-hCD25, indicating effect of Activin stimulation alone (left panel) compared to Activin
followed by exposure to the BMP and TGFb inhibitors Noggin and SB431542 (Nog/SB) for 24 hr.
(C) Nkx2-1GFP knockin mouse embryo and lungwhole mount (both at E14.5) with GFP fluorescence visible in the forebrain, thyroid, and lung (thyroid in Figure S2).
In the lung and trachea, fluorescence appears in an epithelial pattern (Tr; arrowhead).
(D) Effect of Nog/SB exposure on the competence of day 5 cells to specify to Nkx2-1+ endoderm by day 14. Representative flow cytometry dot plots and summary
bar graph indicate percentages of GFP+ cells in each condition (n = 4; average ± SEM; *p < 0.001). qRT-PCR analysis of indicated genes comparing day 14 sorted
GFP+ to GFP cells (bars = average fold change in gene expression ± SD).
(E) Effect of WFKBE with versus without FGF2 supplementation on GFP+ cell morphology. GFP fluorescence and phase contrast overlay images are shown
for D12 (presort) ESC-derived GFP+ cells, which occur only rarely in the absence of FGF2 (top panel) and express neuroectodermal markers such as Pax6
(data not shown). In contrast, GFP+ outgrowth cells in presence of FGF2 (lower panel) show a different morphology and are endodermal (see markers in D).
Scale bar = 100 mm.
(F) Prolonged Nog/SB exposure specifies Nkx2-1+ neuronal cells by day 13, as indicated by flow cytometry and kinetics of induction of neuronal markers
(Olig2 and Tuj1), loss of endodermal marker Foxa2, and loss of early thyroid marker Pax8.
See also Figures S1–S4.
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(Green et al., 2011; Kattman et al., 2011), we tested stage-
specific modulation of these pathways prior to Foxa3 induction
in our system. Exposing day 4 or 5 cells to Noggin and400 Cell Stem Cell 10, 398–411, April 6, 2012 ª2012 Elsevier Inc.SB431542 (hereafter Nog/SB), inhibitors of BMP and Activin/
TGFb signaling, respectively, we were able to minimize Foxa3
induction while maintaining anterior endodermal markers, such
as Sox2 and Tbx1 (Figure 1B and Figure S4).
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derived endoderm more competent to specify into Nkx2-1+
endodermal cells. Using the Nkx2-1GFP ESC line, we found
that only cells exposed to 24 hr of Nog/SB were competent to
induce endodermal Nkx2-1GFP in 21.3% ± 2.7% (average ±
SD) of cells (Figure 1). To induce Nkx2-1 following Nog/SB treat-
ment, we exposed the competent cells to high doses of FGF2
(500 ng/ml) combined with Wnt3a, FGF10, KGF, BMP4, EGF,
and heparin; hereafter WFKBE+F2/H. We have previously re-
ported thatWFKBE possesses endodermal ventralizing capacity
in human ESC-endoderm (Green et al., 2011). However, only
when supplementing the WFKBE cocktail with FGF2 in mouse
ESCs did we observe efficient derivation of Nkx2-1GFP+ cells.
TheWFKBE+F2/H combination only induced efficient Nkx2-1GFP
when ESC-endoderm cells were first exposed to TGFb/BMP
inhibition with Nog/SB (Figure 1D). The sortedGFP+ cells derived
with WFKBE+F2/H expressed an mRNA signature suggesting
that they maintained an endodermal program (Foxa2+), included
thyroid competent cells (evidenced by Pax8), and were depleted
of neuroectodermal Nkx2-1+ contaminants (evidenced by the
absence of Pax6 and Tuj1). In contrast, when rare GFP+ cell clus-
ters were observed in the absence of FGF2, these clusters dis-
played a distinct morphology (Figure 1E), expressed Pax6 and
Tuj1, and lacked any detectable expression of Pax8, suggesting
that neuroectodermal rather than endodermal Nkx2-1GFP+ cells
were produced in the absence of FGF2 (data not shown).
Efficient Derivation of Neuroectodermal Nkx2-1+ Cell
Fate by Prolonged TGFb/BMP Inhibition
We anticipated that the duration of TGFb/BMP inhibition would
need to be brief to prevent loss of ESC-endoderm to competing
neuronal cells, based on recent publications indicating that neu-
roectodermal derivatives may be rapidly derived from human
ESCs exposed to these inhibitors (Chambers et al., 2009; Smith
et al., 2008). Indeed, induction of Nkx2-1+ cells of neuroectoder-
mal lineage (Tuj1+ and Olig2+) could be achieved with 70% effi-
ciency after extended exposure of Activin-stimulated ESCs to
Nog/SB beginning on day 4 (prior to robust induction of the
endodermal markers Cxcr4/ckit) and continuing for >48 hr; these
conditions yielded no detectable expression of endodermal lung
or thyroid differentiation (Figure 1F). We concluded that stage-
and time-dependent inhibition of TGFb and BMP signaling
allows precise control over whether Nkx2-1+ endoderm versus
Nkx2-1+ neuroectoderm lineages are derived during in vitro
directed differentiation of ESCs.
Purified Nkx2-1+ Endodermal Progenitors Differentiate
into Thyroid and Lung Lineages
The expression of Foxa2 and Pax8 in purified Nkx2-1+ endoderm
cells suggested the presence of primordial thyroid progenitors in
culture prior to induction of the specific differentiation marker
thyroglobulin. In mouse endoderm development this expression
pattern occurs in developing thyroid epithelial cells between
E8.5–E14.5. No specific markers of lung lineage have been
described in the embryo to confirm the existence of primordial
Nkx2-1+ lung progenitors between E9.0, their moment of identifi-
able lineage specification from endoderm, and E10.5, when the
earliest specific lung epithelial marker, SPC, is first expressed.
Two transcription factors known to be expressed nonspecificallyin early lung endoderm progenitors, Foxp2 and Id2 (Rawlins
et al., 2009; Sherwood et al., 2009), were expressed in Nkx2-
1GFP+ cells (Figure S5); however, both markers were also ex-
pressed in GFP cells.
We sought to test for the presence of potential primordial lung
and thyroid progenitors within the purified Nkx2-1+ population
by assessing whether, as in the embryo, these cells uniquely dis-
played the capacity to undergo further differentiation into more
mature lung or thyroid epithelia, expressing more specific
markers of lineage differentiation. We replated purified GFP+
cells to allow further expansion and differentiation (Figure 2),
and we withdrew Wnt3a, KGF, BMP4, and EGF from the media,
but maintained FGF2 and FGF10. FGF2 has been employed to
specify lung progenitors in endoderm explant cultures (Serls
et al., 2005), and FGF10 has been implicated as necessary for
the maintenance and proliferation of a variety of endodermal-
lineage-specified progenitors, including those of the primordial
lung (Ramasamy et al., 2007). As in the developing embryo,
Nkx2-1+ endodermal progenitors within 1 week of further culture
continued to proliferate and upregulated a constellation of
specific lung epithelial markers, SPC and SPB, as well as prox-
imal airway patterning markers, Scgb3a2 (not shown) and the
Clara cell marker CC10 (CCSP; Scgb1a1) (Figure 2 and Fig-
ure S5). In addition, markers of proximal airway basal cells
(p63) and ciliated cells (Foxj1) emerged as did the cystic fibrosis
transmembrane regulator Cftr, which is expressed on a variety of
endodermal cells, including ciliated cells of the airway. Thyroid
maturation of endodermal Nkx2-1+ cells was also evident during
this period, based on upregulation of thyroglobulin and the
receptor for thyroid stimulating hormone (TSHR; Figure 2 and
Figure S5). In contrast, the sorted GFP population did not
display the capacity to express a lung or thyroid program, as
SPC or thyroglobulin was not detected after replating (data not
shown). In cells deriving from the GFP+ sorted population, there
was no evidence at any time point studied (days 15–25) of upre-
gulation of markers of neuroectoderm (Pax6 or Tuj1), mesoderm
(Myf5), or other endodermal lineages such as liver (AFP or
Albumin; data not shown and Figure 2). Furthermore, <0.1% of
cells derived from the GFP+-sorted cells expressed Tuj1 protein
by immunostaining (Figure 3). Overall, these results suggest
a step-wise sequential progression of ESC-derived Nkx2-1+
endodermal progenitors through differentiation stages reminis-
cent of the described sequence of lung and thyroid development
in vivo.
To determine whether proteins known to be expressed in
endodermal and early lung epithelial cells were present in the
ESC-derived Nkx2-1+ population, we performed dual immunos-
taining for Nkx2-1 protein and Foxa2, Sox2 or Sox9 on day 14
prior to cell sorting and on day 24 after outgrowth of purified
GFP+ cells (Figure 3). We found that the majority of ESC-derived
Nkx2-1+ cells on day 14 coexpressed the endodermal marker
Foxa2. Many Nkx2-1+ cells were proliferating as indicated by
Ki67 immunostaining (Figure 5). In addition, a subset of
Nkx2-1+ cells coexpressed either Sox2 or Sox9 (Figure 3), tran-
scription factors that, in the presence of Nkx2-1 endoderm in the
embryo, mark lineages of the proximal airway (Que et al., 2009)
or distal lung bud epithelium (Perl et al., 2005), respectively. At
the completion of the protocol shown in Figure 2, the GFP+ cells
sorted on day 14 or 15 and replated in culture for 9–10more daysCell Stem Cell 10, 398–411, April 6, 2012 ª2012 Elsevier Inc. 401
Figure 2. Purified Endodermal Nkx2-1GFP+ Progenitors Derived from ESCs Proliferate in Culture and Express a Repertoire of Lung and
Thyroid Lineage Genes
(A) Schematic of culture protocol for directed differentiation of ESCs into Nkx2-1GFP+ cells. (B) Sort gate used to purify GFP+ cells for replating and outgrowth. (C)
Expression of Nkx2-1mRNA and indicatedmarker genes (D) for each cell population, quantified by real time RT-PCR. E18.5 lung and thyroid RNA extracts served
as positive controls. Bars indicate average fold change in gene expression over ESCs ± SEM (n = 3 independent experiments). DCI+K = cells exposed to lung
maturation media from day 22–25. See also Figure S5.
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Figure 3. Purified ESC-Derived Populations Expressing Nkx2-1 Protein Coexpress Markers of Early Developing Endoderm
(A) Heterogeneous ESC-derived cultures on day 14 (D14; 1 day before GFP+ cell sorting) immunostained for Nkx2-1, Foxa2, Sox2, Sox9, and Tuj1 proteins
demonstrate coexpression of Foxa2 in the majority of Nkx2-1+ cells and expression of Sox2 or Sox9 in subsets of Nx2-1+ cells and Nkx2-1 cells. In contrast,
Tuj1+ cells do not overlap with Nkx2-1+ cells. In these wells 16% of all cells were Nkx2-1GFP+ by flow cytometry.
(B) After purification of the Nkx2-1GFP+ cells shown in (A) by flow cytometry on D15, outgrowth cells stained on D24 for each indicated marker show more clearly
defined morphology than before sorting in (A). Arrowhead = rare neuronal (Tuj1+) cell found after cell sorting. At this D24 time point,60% of cells retained Nkx2-
1GFP expression by flow cytometry. Scale bar = 100 mm. Nuclei are counterstained with DAPI (blue).
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outgrowth, and Foxa2, Sox2, and Sox9 protein expression was
still detected in subsets of Nkx2-1+ cells (Figure 3). By day 25,
approximately 40% of the sorted, replated GFP+ population
had downregulated Nkx2-1GFP expression, and a portion of
these Nkx2-1 cells expressed the type 1 alveolar epithelial
cell (AEC1) marker, T1a (Figure 4A and Figure 6), a gene kinetic
typical of late fetal AEC1 development. In order to track SPC+
cell outgrowth, we employed two independent techniques (Fig-
ure 4B): we identified patches of cells expressing pro-SPC
protein by immunostaining day 25 cells, and we assayed for
SPC promoter activity using a lentiviral vector (Figure S6) encod-
ing the dsRed reporter gene expressed under regulatory control
of a published 3.7 kb SPC promoter fragment (Glasser et al.,
1991). We observed SPC-dsRed reporter expression only in
subsets of Nkx2-1GFP+ cells.
ESC-Derived Nkx2-1+ Lung Progenitors Respond
to Fetal Lung Maturation Media and Recellularize 3D
Lung Tissue Scaffolds
A known feature of primary fetal lung epithelial cells late in devel-
opment is their capacity to respond in vitro to cyclic AMP and
steroid-containing media by augmenting the expression of lung
epithelial-specific genes, such as surfactant proteins (Gonzaleset al., 2002). Hence, beginning on day 22 of our culture protocol,
we started a 3 day treatment of the ESC-derived Nkx2-1GFP+
cells with dexamethasone, cyclic AMP, IBMX, and KGF, here-
after ‘‘DCI+K,’’ a defined serum-free media previously shown
to induce well-characterized global transcriptome changes in
fetal lung epithelial cells. We found that DCI+K treatment
induced 100-fold upregulation of lung epithelial gene expres-
sion (SPC, SPB, and CC10) in the purified Nkx2-1GFP+ progeny
(Figure 2 and Figure S5), but did not detectably augment thyroid
marker gene expression (TSHR or thyroglobulin). Epithelial-like
sheets were also evident histologically at this time, as evidenced
by f-actin filament orientation after phalloidin staining (Figure S5).
In contrast 3 days of exposure to thyroid maturation media (TSH,
IGF-1, and NaI) resulted in no increase in lung marker gene
expression, but induced upregulation of the thyroid markers
thyroglobulin and TSHR (Figure S5D).
Since structure and function are inextricably linked features of
lung alveolar epithelial cells, we assessed the capacity of sorted
day 15 Nkx2-1GFP+ progenitors to regenerate 3D alveolar lung
structure (Figures 4C–4H and Figure S7). The capacity of primary
lung epithelial cells to seed decellularized rodent lung scaffolds
is one assay recently developed to test the regenerative potential
of lung epithelia (Daly et al., 2012; Ott et al., 2010; Petersen et al.,
2010). Sorted day 15 Nkx2-1GFP+ ESC-derived cells, deliveredCell Stem Cell 10, 398–411, April 6, 2012 ª2012 Elsevier Inc. 403
Figure 4. Alveolar Differentiation Repertoire of ESC-Derived Nkx2-1+ Lung Progenitors
(A and B) Immunostaining for alveolar epithelial markers T1a, pro-SPC, and Nkx2-1 on cells at the completion of the 25 day directed differentiation protocol. ESCs
sorted on day 15 based on Nkx2-1GFP+ expression subsequently gave rise to (A) cells reminiscent of type 1 alveolar epithelial cells (AEC1) as they lost Nkx2-1
nuclear protein expression (green immunostain) while expressing T1a protein. (B) Other patches of cells appeared more reminiscent of distal SPC+ alveolar
epithelial cells as they expressed punctate cytoplasmic pro-SPC protein and displayed SPC promoter activation while retaining Nkx2-1GFP expression. Arrow =
SPC-dsRed and Nkx2-1GFP coexpressing cell (orange). Arrowhead = cell expressing only Nkx2-1GFP.
(C) Schematic summarizing the decellularization-recellularization assay.
(D) H&E stains of lung sections showing lung scaffold appearance with no recellularization (left panel) versus hypercellular sheets following reseeding with
undifferentiated ESCs (middle panel) versus cells of alveolar structural morphologies after seeding with Nkx2-1GFP+ purified ESC-derived progenitors (right
panel). Scale bars = 100 mm in three left panels. Zoom of the indicated boxed region is shown in far right panel with scale bar = 20 mm.
(E and F) Nkx2-1+ nuclear protein (brown; arrowheads in E) immunostaining of engrafted cuboidal epithelial cells in the corners of alveoli, derived 10 days after
reseedingwith Nkx2-1GFP+ sorted cells. Arrow = flattened nucleus of anNkx2-1 negative cell (purple) lining the alveolar septum.Many of these flattened cells were
T1a+ (F; arrowhead). Scale bars = 20 mm.
(G) Control mouse lung without decellularization showing T1a apical membrane staining pattern (brown) of mature AEC1. See also Figure S7.
(H) Ciliated airway epithelial cell (arrow) 10 days after reseeding with differentiated/unsorted ESC-derived cells. Scale bar = 20 mm. All nuclei were counterstained
with hematoxylin (purple).
See also Figures S6 and S7.
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ESC-Derived Lung/Thyroid Progenitorsby intratracheal instillation into decellularized murine lungs, were
able to seed alveolar lung regions and adopt the morphology of
lung alveolar epithelia (Figures 4C–4H and Figure S7). In explant
cultures of lung tissue reseeded with GFP+ cells on day 15 and
cultured for 10 more days, 71% ± 12% (average ± SD) of en-
grafted cells maintained GFP fluorescence and continued to
express nuclear Nkx2-1 protein (Figure 4E). Some engrafted
cells acquired a flattened morphology and lost expression of
Nkx2-1 protein, a pattern reminiscent of developing AEC1 cells
in vivo (Williams, 2003). Consistent with this pattern, the majority
of these flattened cells expressed the AEC1 marker protein T1a
(Figures 4F and 4G), but lacked expression of Nkx2-1 protein by
costaining (Figure S7G). In contrast, day 0 undifferentiated cells
did not form alveolar structures after intratracheal instillation, but
rather gave rise to masses of cells in the distal lung (Figure 4D)
with only very rare cells (<0.1%) expressing either Nkx2-1 or
T1a proteins (Figure S7). Counting cell nuclei present 10 days
after reseeding revealed that lung slices reseeded with undiffer-
entiated ESCs contained more cellular outgrowth than slices
reseeded with differentiated cells, but the seeded cells deriving
from undifferentiated ESCs remained round, and none of these
undifferentiated cells developed either the morphologic or
molecular features of lung epithelia (Figure S7). Although ciliated
cells were not observed after reseeding with sorted cells, day 15
unsorted, differentiated cells (containing 20% GFP+ and 80%
GFP cell mixtures) were able to re-epithelialize proximal
airways and gave rise to ciliated cells facing the airway lumen
(Figure 4H).
BMP and FGF Signaling Is Required for Efficient Lineage
Specification of Nkx2-1+ Endodermal Progenitors
To identify factors essential for lung and thyroid lineage specifi-
cation of endoderm, we tested the effects of removing each of
the six growth factors from our WFKBE+F2/H cocktail. Both
FGF2 andBMP4were essential for efficient Nkx2-1+ endodermal
lineage specification, as removal of either factor resulted in a
significant decrease in the percentage of GFP+ cells (Figures
5A and 5B; p < 0.05). In contrast, EGF, KGF, and FGF10 were
each dispensable for Nkx2-1 lineage specification with no signif-
icant decrement in the percentage of GFP+ cells induced in the
absence of these growth factors. Removal of Wnt3a did not
affect the percentage of GFP+ cells induced by day 14. However,
it markedly reduced proliferation of day 14 cells, as assessed by
the 24 hr BrdU labeling index, which declined from 89%BrdU+ in
the presence of Wnt3a to 40% BrdU+ in the absence of Wnt3a
(Figure 5B). Removal of EGF, KGF, or FGF10 did not significantly
alter the BrdU labeling index of the day 14 population. Taken
together our results suggested that efficient induction of
Nkx2-1 in endodermal progenitors depends on stage-specific
and time-dependent inhibition of BMP and TGFb signaling fol-
lowed by reinitiation of BMP signaling together with FGF
signaling.
Initial Lineage Commitment of Nkx2-1+ versus Nkx2-1–
Cells Is Associated with Definable Changes in the
Genetic and Epigenetic Programs of Each Population
An attractive feature of ESC-based in vitro developmental
systems is the potential to use them to learn about genetic or
epigenetic programs that are otherwise difficult to study in vivo.We found that by day 14 of differentiation, cells treated with our
protocol already exhibited significant restriction of cell fates,
because only sorted Nkx2-1GFP+ cells at this time could go on
to express lung or thyroid markers. In contrast, day 12 or day
14 sorted GFP cells, when replated, did not express GFP,
Nkx2-1, or differentiated lung/thyroid markers even after pro-
longed culture periods in either culture condition (WFKBE+F2/
H or FGF2+10; Figures 6A and 6B). We reasoned that the epige-
netic signature of the Nkx2-1 locus might also distinguish these
cell populations. We extracted DNA and chromatin from ESC
populations of various developmental stages (undifferentiated,
definitive endodermal prior to Nkx2-1 induction, and endodermal
day 12 GFP+ versus GFP sorted cells) and from primary post-
natal lung cells sorted based on expression of Nkx2-1GFP+
(epithelial) versus Nkx2-1GFP (including lung mesenchyme
and endothelium) (Figure 6). Regardless of developmental stage,
all CpG sites in this Nkx2-1 promoter region were unmethylated.
In contrast, the histone methylation signature in this promoter
region in differentiated day 12 GFP ESC-derived cells exhibited
a repressive trimethylated histone modification mark (H3K27-
me3), which correlated with the ESC-derived GFP population’s
cell fate decision to lose endodermal lung/thyroid differentiation
capacity. This same repressive mark was found in Nkx2-1GFP
sorted primary cells and contrasted with the combined active
(H3K4-me3) and repressive (H3K9-me3 and H3K27-me3) marks
seen in populations of undifferentiated ESCs and endoderm
staged cells, and the predominantly active mark (H3K4-me3)
observed in ESC-derived Nkx2-1GFP+ and primary Nkx2-1GFP+
cells (Figure 6C). The finding that histone modifications rather
than DNA CpG methylations occur in key Nkx2-1 regulatory
regions early in endoderm development is consistent with
descriptions of epigenetic changes in loci encoding other key
endodermal transcription factors (Zaret et al., 2008).
In contrast to Nkx2-1, the proximal promoter region of Oct4
exhibited both DNA methylation and repressive histone marks
(H3K9-me3 and H3K27-me3) soon after endodermal differentia-
tion (Figure 6D), consistent with silencing of a locus that will not
be expressed in Nkx2-1+ progenitors or their epithelial progeny.
Finally, we sought to apply our in vitro model system to define
the global genetic program of the putative primordial Nkx2-1+
endodermal progenitors. We performed microarray analysis of
global transcriptomes isolated from GFP+ versus GFP day 14
ESC-derived cells. We found that 1,267 probes out of 29,000
were differentially expressed at FDR-adjusted p < 0.05. As
expected, Nkx2-1 was found to be the most statistically sig-
nificant differentially expressed transcript (p = 1.19 3 105;
Figures 7A–7C). These 1,267 differentially expressed genes
provided a genetic signature that characterizes the ESC-derived
Nkx2-1+ endodermal progenitor population, including 83 novel
candidate cell surface markers that are upregulated in the
GFP+ population (Table S1). In addition, this GFP+ genetic signa-
ture included additional genes known to characterize early
developing thyroid and lung in vivo as well as potential ligand-
receptor relationships active in signaling cascades (Notch,
Wnt, RA, and BMP signaling) that have been shown to play a
role in early lung/thyroid development (Cardoso and Lu¨, 2006).
Focusing on the set of 594 genes significantly upregulated in
Nkx2-1GFP+ cells, we performed gene ontology analysis,
revealing five major biological process groupings (Figure 7B)Cell Stem Cell 10, 398–411, April 6, 2012 ª2012 Elsevier Inc. 405
Figure 5. Combinatorial FGF and BMP Signaling Promotes Efficient Derivation of Proliferating Nkx2-1GFP+ ESC-Derived Cells
(A) Percentage of Nkx2-1GFP+ cells derived from ESCs on D14 when individual growth factors were withdrawn from the six-factor (6F) ventralizing WFKBE+FGF2
cocktail. Two-tailed t test, *p < 0.05.
(B) BrdU labeling index (after 24 hr versus 0 hr of BrdU exposure) measured by flow cytometry in each condition from (A). Cells are scored as BrdU+ based on
histogram gates set on cells that did not receive BrdU.
(C) Immunostaining for Nkx2-1 and Ki67 nuclear proteins in D15 ESC-derived cells.
(D) Model of directed differentiation of ESCs into neuroectodermal Nkx2-1+ cells versus endodermal Nkx2-1+ cells with lung and thyroid differentiation potential.
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ESC-Derived Lung/Thyroid Progenitorsrepresented by this gene set. The two most prominent biological
processes represented in this set were related to either develop-
ment or regulation of cellular processes. Within the differentially
expressed gene set of the GFP population, upregulation of
Col1a1, Col1a2, Twist, Gli1, Gli3, and PDGFRa suggested the
presence of mesenchymal lineages (Figure 7B).
By comparing the transcriptome of our ESC-derived Nkx2-1+
progenitors to databases established from in vivo tissues,
we found that 17% of genes (100 out of 594) upregulated in
Nkx2-1GFP+ cells were also expressed in the E11.5 developing
mouse lung epithelium (Lu¨ et al., 2005). Finally, we determined
which of the 594 upregulated genes in Nkx2-1GFP+ cells overlap-
ped with published targets of Nkx2-1 protein binding in the
developing lung. Twelve percent of these genes (71 out of 594)
were targets of Nkx2-1 identified previously (GEO GSE23043)
(Tagne et al., 2012) by microarray analysis of chromatin (‘‘ChIP
on chip’’) immunoprecipitated from E11.5 lung epithelial cells
using anti-Nkx2-1 antibodies (Figure 7D).406 Cell Stem Cell 10, 398–411, April 6, 2012 ª2012 Elsevier Inc.DISCUSSION
Our results demonstrate the directed differentiation of pluripo-
tent stem cells in serum-free culture into purified Nkx2-1+ endo-
dermal progenitors with lung and thyroid differentiation potential.
We refer to the progenitors purified in 12–15 days with this
approach as ‘‘primordial’’ because they resemble an in vivo
developmental stage (approximating E8.5–E10.5 in mouse
development) where Nkx2-1+ endodermal progenitors have not
yet expressed markers of differentiated lung or thyroid epithe-
lium. Our protocol is the result of an approachwherein we sought
to optimize the differentiation efficiency of each developmental
stage prior to inducing the subsequent desired stage. We then
reassessed the phenotype of the resulting cells when a stage
was identified that seemed resistant to subsequent desired
lineage specification. Using this approach we found definitive
endoderm staged cells derived after optimization of Activin
dose and timing appeared resistant to lung or thyroid lineage
Figure 6. Epigenetic Changes in the Nkx2-1 and Oct4 Proximal Promoter Regions during Directed Differentiation of ESCs
(A) Schematic of cell fate decision in ESC-derived endodermal cells to commit to an Nkx2-1 descendant lineage.
(B) Kinetics of Nkx2-1GFP expression during 22 days of ESC-directed differentiation, following the protocol shown in Figure 2.
(C and D) Chromatin immunoprecipitation and bisulfite sequencing studies demonstrate the DNA methylation and histone trimethylation states of the proximal
promoters of the Nkx2-1 and Oct4 loci in each cell population during development. Arrows and numbers indicate PCR primer binding sites relative to the ATG
start site. Open circles = unmethylated DNA CpG sites; closed circles = methylated CpG sites. Lung Nkx2-1GFP+ versus Nkx2-1GFP– samples were prepared by
sorting primary lung cell digests from a 3-week-old mouse. MLE-15 = mouse lung epithelial cell line.
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TGFb signaling pathways were we able to yield these endo-
dermal progenitors amenable to efficient lung/thyroid lineage
specification. Using this strategy, the optimized protocol pre-
sented here results in approximately 160 Nkx2-1GFP+ endo-
dermal cells per starting input ESC within 14 days of directed
differentiation.
Our studies reinforce the importance of mechanisms, such as
FGF and BMP signaling, that have recently been proposed as
key inducers of lung lineage within foregut endoderm (Domyan
et al., 2011; Serls et al., 2005). Although these pathways have
been singly manipulated in vivo using genetic mouse models,
our results indicate that no single pathway alone appears to be
sufficient for efficient lung or thyroid lineage specification from
developing endoderm. Most importantly, our results emphasize
that precise inhibition of certain pathways at defined stages is asimportant as the addition of pathway stimulators at different
developmental stages (model shown in Figure 5D). The combi-
nation of the two approaches, stage-specific selective inhibition
combined with induction of key signals, is likely to be a common
strategy that can be applied regardless of the germ layer or
tissue system to be derived in vitro or in vivo (Kattman et al.,
2011).
During the course of our studies we derived putative progeni-
tors reminiscent of a developmental period (E9–E10.5) that is
devoid of known specific markers for lung primordial progeni-
tors. It was useful to develop simple marker gene signatures as
indicators of passage through each sequential milestone on
the way to lung/thyroid differentiation. For adequate response
to Activin, we monitored for the onset of robust and efficient
Cxcr4/ckit expression prior to initiating 24 hr of BMP/TGFb inhi-
bition. During the subsequent stage of FGF andBMP stimulation,Cell Stem Cell 10, 398–411, April 6, 2012 ª2012 Elsevier Inc. 407
Figure 7. Differentially Expressed Genes in ESC-Derived Nkx2-1GFP+ versus Nkx2-1GFP– Cells
(A) Heat map of 1,267 genes differentially expressed between triplicate samples of Nkx2-1GFP+ versus Nkx2-1GFP ESC-derived cells, sorted on day 14 of
differentiation.
(B) Gene Ontology analysis of the 594 genes upregulated in GFP+ cells (DAVID on-line analysis).
(C and D) Selections of the 1,267 differentially expressed genes (C) demonstrate differing gene programs relating to thyroid lineage, epithelial signaling,
and mesenchymal programs, or (D) genes whose promoters are known targets of Nkx2-1 protein binding in E11.5 embryonic lung epithelial cells in vivo.
Gene.symb = NCBI gene ID. LogFC = log2 fold change in gene expression.
See also Table S1.
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dermal progenitors had confirmed expression of Foxa2 and
absence of expression of Pax6 and Tuj1 in order to ensure
that lung competent endoderm, rather than neuroectodermal
Nkx2-1 progenitors, had been derived. The presence of Pax8
expression at this time can also be used to verify that Nkx2-1
endoderm of thyroid lineage has been derived. Since no specific
markers of lung or thyroid have yet been described to prove
definitively that candidate progenitors are of lung/thyroid
lineage, demonstration of subsequent induction of specific
differentiated lung and thyroid epithelial markers (e.g., surfactant
proteins and thyroglobulin, respectively) remains the only reliable
proof of the lung/thyroid competence of the putative primordial
Nkx2-1+ progenitors being derived.
A particularly striking and serendipitous outcome of our
experiments is the development of a simple protocol for the408 Cell Stem Cell 10, 398–411, April 6, 2012 ª2012 Elsevier Inc.highly efficient derivation of Nkx2-1+ neuroectodermal cells by
prolonged inhibition of BMP/TGFb signaling in ESCs. Although
Nkx2-1 is expressed in three lineages across two germ layers
in the developing embryo, stage-specific optimization of inhibi-
tion of BMP and TGFb signaling pathways, as demonstrated
here, can effectively direct the fate of the resulting Nkx2-1+ cells
preferentially to either germ layer. In the ectodermal germ layer of
the developing embryo, Nkx2-1 is expressed in forebrain
neuronal and oligodendrocyte progenitors. Consistent with
these lineages, ESC-derived neuroectodermal Nkx2-1GFP+ cells
generated in our neuronal conditions expressed Tuj1, Pax6,
and Olig2; however, whether they also express the full constella-
tion of forebrain markers will require further study and in vivo
correlation. It is well known that neuroectoderm differentiates
easily from undifferentiated ESCs, particularly when BMP and
TGFb signaling are inhibited, and it appears that Nkx2-1+
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ESC-Derived Lung/Thyroid Progenitorsneuroectodermal progenitors may be similarly derived from
undifferentiated mouse ESCs by this approach or by recently
published alternate protocols for human NKX2-1 reporter ESCs
(Goulburn et al., 2011).
A useful outcome for lung and thyroid research will be the
utilization of this in vitro platform for the identification of new
lineage markers and the study of genetic and epigenetic
programs active in early lung and thyroid development. Although
the gene programs and potential markers identified in vitro will
require validation in vivo in the developing embryo, we have
demonstrated how this system might be applied to define the
genetic program of Nkx2-1+ endodermal progenitors. We found
83 cell surface markers that potentially distinguish the Nkx2-1+
endodermal progenitors in our system, andwe observed a defin-
able epigenetic change in the Nkx2-1 promoter region that
correlates with lineage commitment of Nkx2-1 cells away
from lung or thyroid competence.
There are several issues raised by our studies. First, we
acknowledge that a lack of any known genetic or epigenetic
signature of authentic in vivo Nkx2-1+ endodermal progenitors
of similar stage limits our ability to properly compare the pheno-
type or the genetic signature of the in-vitro-derived Nkx2-1+
endodermal population against their authentic in vivo correlates.
Application of the Nkx2-1 reporter mouse introduced here for
the purification of primordial Nkx2-1 endodermal thyroid and
lung progenitors from developing mouse embryos will help to
surmount this hurdle. Second, the relative frequency of thyroid-
versus lung-committed progenitors within the Nkx2-1GFP+ endo-
dermal population needs to be more precisely quantified. This
will first require the discovery of new markers specific to primor-
dial lung epithelia prior to the E10.5 time at which the earliest
known marker, SPC, is expressed in the mouse developing
lung. Alternatively, we have not excluded the intriguing possi-
bility that the Nkx2-1+ progenitors derived from ESCs in vitro
express bipotential features of both thyroid and lung progenitors,
a differentiation repertoire that is not known to occur in vivo in
endoderm development. Future work with our system, focused
on testing clonogenicity and multipotency of the Nkx2-1+ popu-
lation, will help to address these questions. Finally, we empha-
size that lung or thyroid progenitors must ultimately be defined
by their capacity to give rise to functional epithelia that produce
appropriate thyroid hormones or allow pulmonary gas exchange.
The lack of known functional assays or reproducible in vivo
engraftment models to functionally test candidate lung epithelial
progenitors continues to limit progress in lung progenitor cell
biology. Novel functional assays of lung epithelia, such as the
recellularization of decellularized lung scaffolds employed by
us and others, may provide bioartificial lungs (Ott et al., 2010)
that can serve as one platform for in vitro and in vivo testing of
candidate lung epithelial progenitors, such as those derived
from ESCs.
In conclusion, we present here tools and protocols for the
step-wise derivation, purification, and culture expansion of
primordial lung and thyroid endodermal progenitors from plurip-
otent stem cells. Since primordial lung and thyroid progenitors
are few in number in vivo and are thought to only transiently
occur during early anterior foregut endodermal development,
this in vitro system allows the capture of a developmental stage
in culture that is otherwise difficult to study in vivo. Thus, whenpartnered with in vivo studies, this in vitro system should allow
high-resolution study of the mechanisms and genetic/epigenetic
programs of cells that to date remain virtually unstudied in devel-
opmental biology. Derivation of a potentially unlimited supply of
early Nkx2-1+ lung and thyroid progenitors from ESCs should
also allow the purification of progenitors for the modeling and
potential treatment of themany diseases affecting lung or thyroid
epithelia.
EXPERIMENTAL PROCEDURES
Derivation of Nkx2-1GFP ESCs and Reporter Mice
The enhancedGFP reporter genewas targeted to one allele of the endogenous
Nkx2-1 locus by homologous recombination in W4/129S6 ESCs (Taconic,
Hudson, NY), replacing endogenous sequences from the second ATG start
site through the end of the Nkx2-1 homeobox (positions 7957–9480 in Gen-
Bank locus MMU19755), according to methods detailed in the Supplemental
Information. Nkx2-1GFP ESCs were injected into C57BL/6j (Jackson Labora-
tory) mouse blastocysts to generate knockin mice as detailed in the Supple-
mental Information. All mouse work was approved by the Institutional Animal
Care and Use Committee of Boston University.
ESC Culture and Differentiation
The Nkx2-1GFP ESC line was maintained in the undifferentiated state in serum-
free, feeder-free culture conditions using ‘‘2i’’ media (Ying et al., 2008). Five
days of definitive endoderm induction in serum-free conditions was performed
using 50 ng/ml Activin as previously published (Gouon-Evans et al., 2006) and
detailed in the Supplemental Information and Figure S2. On day 5 EBs were
plated onto gelatin-coated plates. Media was switched to Nog/SB media:
cSFDM supplemented with 100 ng/ml mNoggin (R&D) and 10 mM SB431542
(Sigma). After 24 hr the media was switched to Nkx2-1 induction media:
cSFDM supplemented with 100 ng/ml mWnt3a, 10 ng/ml mKGF, 10 ng/ml
hFGF10, 10 ng/ml mBMP4, 20 ng/ml hEGF, 500 ng/ml mFGF2 (all from
R&D), and 100 ng/ml Heparin Sodium Salt (Sigma). Nkx2-1GFP+ cells were
sorted and replated onto gelatin-coated dishes on the day indicated in the
text (day 12–15). Replated cells were grown for 7 days in cSFDM supple-
mented with mFGF2 (500 ng/ml), hFGF10 (100 ng/ml), and 100 ng/ml Heparin
Sodium Salt (Sigma). On day 22, where indicated in the text, the media was
switched to lungmaturation media (DCI+K): Ham’s F12media +15mMHEPES
(pH 7.4) +0.8 mM CaCl2 +0.25% BSA + 5 mg/ml insulin + 5 mg/ml transferrin +
5 ng/ml Na selenite + 50 nM Dexamethasone + 0.1 mM 8-Br-cAMP + 0.1 mM
IBMX + 10 ng/ml KGF. Detailed protocols are available in the Supplemental
Information.
Immunofluorescent Staining
Cells cultured on gelatin-coated 96-well plates were fixed with fresh 4% para-
formaldehyde and immunostained with the indicated antibody according to
methods detailed in the Supplemental Information.
Quantitative RT-PCR
Quantitative (real time) PCR amplification of cDNA was performed using
Taqman probes. Relative gene expression, normalized to 18S control, was
calculated using the 2(DDCT) method to quantify fold change in gene expres-
sion of the indicated gene compared to baseline expression (fold change =
1) in ESCs. Undetectable genes were assigned a cycle number of 40. Detailed
methods and primer sequences are available in the Supplemental Information.
Mouse Lung Recellularization and Culture
B6 mouse lungs were decellularized and recellularized according to recently
described methods (Daly et al., 2012; Wallis et al., 2012). Following decellula-
rization, the right main-stem bronchus was ligated to allow intratracheal
delivery of cells only to the left lung. One million cells of each population
indicated in the text were mixed with 2% low-melting temperature agarose
and intratracheally injected into the decellularized left lung. Each lung was
sectioned sagitally into 2 mm thick slices and cultured for 10 days (equivalent
to days 15–25 of the protocol shown in Figure 2). On day 25, paraffin sectionsCell Stem Cell 10, 398–411, April 6, 2012 ª2012 Elsevier Inc. 409
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ESC-Derived Lung/Thyroid Progenitorsof 4% paraformaldehyde-fixed lung slices were prepared for immunohisto-
chemistry analyses detailed in the Supplemental Information.
Bisulfite Sequencing and ChIP
Genomic DNA was purified and bisulfite treated as published (Cao et al., 2010)
prior to nested PCR of the indicated promoter region, using primers and
methods detailed in the Supplemental Information. ChIP of 500–2,000 bp
chromatin fragments was performed using anti-H3K4me3 antibodies,
H3K9me3 antibodies, H3K27me3 antibodies, or IgG isotype control as
detailed in the Supplemental Information.
Statistical and Microarray Methods
Unless otherwise indicated all statistical comparisons between groups were
performed by two-tailed student’s t test, and p < 0.05 indicated a statistically
significant difference between groups. Detailed statistical methods of analysis
of Affymetrix GeneChip Mouse Gene 1.0 ST arrays are included in the
Supplemental Information.
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